{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:46:06Z","timestamp":1782819966145,"version":"3.54.5"},"reference-count":126,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wilkie Calvert","award":["DRC24-067"],"award-info":[{"award-number":["DRC24-067"]}]},{"DOI":"10.13039\/501100000839","name":"University of Reading","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000839","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prolonged intravenous (IV) antibiotic therapy in hospitalized patients with pneumonia increases healthcare costs and hospital length of stay compared to oral (PO) therapy. Antimicrobial stewardship (AMS) interventions promoting timely IV-to-PO antibiotic conversion may reduce healthcare burden without compromising patient outcomes. Optimal design and implementation of such interventions in different healthcare settings, including respiratory medicine remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aim of this study was to evaluate the effectiveness of interventions designed to improve IV-to-PO antibiotic switching practices in managing community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The review was registered with PROSPERO (CRD420251039180). PubMed, Scopus, Web of Science, The Cochrane Library databases were searched for studies published from 1995 to 2024 focusing on CAP and\/or HAP management or antimicrobials indicated for respiratory infections. Two reviewers independently screened studies using a priori inclusion\/exclusion criteria. Study quality was assessed using the Mixed Methods Appraisal Tool. Data were analysed using narrative synthesis. Clinical outcomes (cure rates, mortality, length of stay), economic outcomes (cost savings), and process measures (switching rates, IV antibiotic duration) were examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>58 studies were included. Interventions included clinical guideline\/protocol implementation (n\u200a=\u200a40), pharmacist-led interventions (n\u200a=\u200a21), educational programmes (n\u200a=\u200a7), computerized decision support systems (n\u200a=\u200a5), audit\/feedback systems (n\u200a=\u200a3), and multidisciplinary team approaches (n\u200a=\u200a1). Most studies demonstrated 1\u20134-day reductions in IV antibiotic duration, 1\u20132\u2005day reductions in hospital length of stay, and cost savings, while maintaining equivalent clinical outcomes. Multimodal approaches outperformed single interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Existing AMS interventions effectively promote IV-to-PO switching in CAP\/HAP management. Healthcare systems should consider more than one intervention to optimize IV-to-PO antibiotic switch.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jacamr\/dlag065","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:29:42Z","timestamp":1776166182000},"source":"Crossref","is-referenced-by-count":0,"title":["The effectiveness of intravenous (IV) to oral (PO) antibiotic switch (IVOS) interventions in managing community- and hospital-acquired pneumonia\u2014a systematic review"],"prefix":"10.1093","volume":"8","author":[{"given":"Nketia","family":"Obed-Arthur","sequence":"first","affiliation":[{"name":"School of Pharmacy, University of Reading , Whiteknights Campus, Reading, England RG6 2AH ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1705-1480","authenticated-orcid":false,"given":"Rosemary H M","family":"Lim","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Reading , Whiteknights Campus, Reading, England RG6 2AH ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Dunsmure","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Reading , Whiteknights Campus, Reading, England RG6 2AH ,","place":["UK"]},{"name":"Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital , Headley Way, Headington, Oxford OX3 9DU ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"2026063005522264800_dlag065-B1","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1128\/CMR.18.4.638-656.2005","article-title":"Antimicrobial stewardship programs in health care systems","volume":"18","author":"Macdougall","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"2026063005522264800_dlag065-B2","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1002\/jhm.881","article-title":"Antimicrobial stewardship for inpatient facilities","volume":"6","author":"Ohl","year":"2011","journal-title":"J Hosp Med"},{"key":"2026063005522264800_dlag065-B3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3947\/ic.2017.49.1.31","article-title":"Impact of intervention by an antimicrobial stewardship team on conversion from intravenous to oral fluoroquinolones","volume":"49","author":"Park","year":"2017","journal-title":"Infect Chemother"},{"key":"2026063005522264800_dlag065-B4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s11096-010-9475-9","article-title":"Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study","volume":"33","author":"Dunn","year":"2011","journal-title":"Int J Clin Pharm"},{"key":"2026063005522264800_dlag065-B5","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlaf146","article-title":"PO-llution Control: a cross-sectional study on the role of antimicrobial stewardship in reducing healthcare\u2019s carbon footprint","volume":"7","author":"Ali","year":"2025","journal-title":"JAC Antimicrob Resist"},{"key":"2026063005522264800_dlag065-B6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/clinids\/24.3.457","article-title":"Oral administration of antibiotics: a rational alternative to the parenteral route","volume":"24","author":"Macgregor","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2026063005522264800_dlag065-B7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12062086","article-title":"Development of national antimicrobial intravenous-to-oral switch criteria and decision aid","volume":"12","author":"Harvey","year":"2023","journal-title":"J Clin Med"},{"key":"2026063005522264800_dlag065-B8","doi-asserted-by":"publisher","first-page":"ii23","DOI":"10.1093\/ijpp\/riac089.027","article-title":"Development of evidence-based UK-wide antimicrobial intravenous-to-oral switch criteria: a DELPHI consensus process","volume":"30","author":"Harvey","year":"2022","journal-title":"Int J Pharm Pract"},{"key":"2026063005522264800_dlag065-B9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3201\/eid1202.050145","article-title":"Systematic review of antimicrobial drug prescribing in hospitals","volume":"12","author":"Davey","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"2026063005522264800_dlag065-B10","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.amjmed.2008.05.010","article-title":"Declining length of hospital stay for pneumonia and postdischarge outcomes","volume":"121","author":"Capelastegui","year":"2008","journal-title":"Am J Med"},{"key":"2026063005522264800_dlag065-B11","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1086\/423960","article-title":"Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study","volume":"39","author":"Capelastegui","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2026063005522264800_dlag065-B12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01672-2023","article-title":"World pneumonia day 2023: the rising global threat of pneumonia and what we must do about it","volume":"62","author":"Cilloniz","year":"2023","journal-title":"Eur Respir J"},{"key":"2026063005522264800_dlag065-B13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41479-017-0039-9","article-title":"Community-acquired pneumonia in the United Kingdom: a call to action","volume":"9","author":"Chalmers","year":"2017","journal-title":"Pneumonia"},{"key":"2026063005522264800_dlag065-B14","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.18203\/2320-6012.ijrms20204883","article-title":"Impact of clinical pharmacist intervention in chronic obstructive pulmonary disease management","volume":"8","author":"Moses","year":"2020","journal-title":"Int J Res Med Sci"},{"key":"2026063005522264800_dlag065-B15","author":"NICE"},{"key":"2026063005522264800_dlag065-B16","doi-asserted-by":"publisher","first-page":"105769","DOI":"10.1016\/j.ijantimicag.2019.07.020","article-title":"Early switching of antibiotic therapy from intravenous to oral using a combination of education, pocket-sized cards and switch advice: a practical intervention resulting in reduced length of hospital stay","volume":"55","author":"Mouwen","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"2026063005522264800_dlag065-B17","doi-asserted-by":"publisher","DOI":"10.1186\/2193-1801-3-717","article-title":"Practice of switch from intravenous to oral antibiotics","volume":"3","author":"Shrayteh","year":"2014","journal-title":"SpringerPlus"},{"key":"2026063005522264800_dlag065-B18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/j.2055-2335.2011.tb00064.x","article-title":"Snapshot of barriers to and indicators for antimicrobial stewardship in Australian hospitals","volume":"41","author":"Chen","year":"2011","journal-title":"J Pharm Pract Res"},{"key":"2026063005522264800_dlag065-B19","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.11.1278","article-title":"Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia","volume":"162","author":"Halm","year":"2002","journal-title":"Arch Intern Med"},{"key":"2026063005522264800_dlag065-B20","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1093\/jac\/dkw129","article-title":"What prevents the intravenous to oral antibiotic switch? A qualitative study of hospital doctors\u2019 accounts of what influences their clinical practice","volume":"71","author":"Broom","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2026063005522264800_dlag065-B21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.rmed.2005.05.009","article-title":"Pharmacokinetic study of pleural fluid penetration of carbapenem antibiotic agents in chemical pleurisy","volume":"100","author":"Niwa","year":"2006","journal-title":"Respir Med"},{"key":"2026063005522264800_dlag065-B22","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1186\/s12879-022-07759-8","article-title":"Analysis of antibiotic use and clinical outcomes in adults with known and suspected pleural empyema","volume":"22","author":"Avner","year":"2022","journal-title":"BMC Infect Dis"},{"key":"2026063005522264800_dlag065-B23","doi-asserted-by":"publisher","first-page":"183.e1","DOI":"10.1016\/j.jamda.2015.11.013","article-title":"Antimicrobial stewardship in long-term care facilities: a call to action","volume":"17","author":"Morrill","year":"2016","journal-title":"J Am Med Dir Assoc"},{"key":"2026063005522264800_dlag065-B24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12875-020-01191-0","article-title":"Antimicrobial stewardship in the primary care setting: from dream to reality?","volume":"21","author":"Avent","year":"2020","journal-title":"BMC Fam Pract"},{"key":"2026063005522264800_dlag065-B25","author":"Thomson"},{"key":"2026063005522264800_dlag065-B26","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/pds.2126","article-title":"Effects of pharmaceutical counselling on antimicrobial use in surgical wards: intervention study with historical control group","volume":"20","author":"Grill","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026063005522264800_dlag065-B27","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/bmj.38993.560984.BE","article-title":"Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial","volume":"333","author":"Oosterheert","year":"2006","journal-title":"BMJ"},{"key":"2026063005522264800_dlag065-B28","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1093\/jac\/dks145","article-title":"Prospective multicentre feasibility study of a quality of care indicator for intravenous to oral switch therapy with highly bioavailable antibiotics","volume":"67","author":"Buyle","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2026063005522264800_dlag065-B29","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/jac\/dkr526","article-title":"Implementation of intravenous to oral antibiotic switch therapy guidelines in the general medical wards of a tertiary-level hospital in South Africa","volume":"67","author":"van Niekerk","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2026063005522264800_dlag065-B30","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1310\/hpj4311-886","article-title":"Economic impact of implementing pneumonia treatment guidelines for intravenous to oral conversion","volume":"43","author":"Emerson","year":"2008","journal-title":"Hosp Pharm"},{"key":"2026063005522264800_dlag065-B31","first-page":"259","article-title":"Comparison of early intravenous to oral switch amoxicillin\/clavulanate with parenteral ceftriaxone in treatment of hospitalized patients with community acquires pneumonia","volume":"21","author":"Yaqub","year":"2005","journal-title":"Pak J Med Sci"},{"key":"2026063005522264800_dlag065-B32","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/s0002-9343(01)00868-3","article-title":"Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial","volume":"111","author":"Castro-Guardiola","year":"2001","journal-title":"Am J Med"},{"key":"2026063005522264800_dlag065-B33","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0149-2918(04)90028-8","article-title":"Evaluation of an algorithm for switching from IV to PO therapy in clinical practice in patients with community-acquired pneumonia","volume":"26","author":"Van der Eerden","year":"2004","journal-title":"Clin Ther"},{"key":"2026063005522264800_dlag065-B34","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1177\/106002809502900601","article-title":"Pharmacoeconomic benefit of antibiotic step-down therapy: converting patents from intravenous ceftriaxone to oral cefpodoxime proxetil","volume":"29","author":"Hendrickson","year":"1995","journal-title":"Ann Pharmacother"},{"key":"2026063005522264800_dlag065-B35","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3760\/cma.j.issn.2095-4352.2015.10.003","article-title":"The significance of multi-criteria decision analysis for the bundle treatment of severe pneumonia","volume":"27","author":"Xu","year":"2015","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"2026063005522264800_dlag065-B36","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.amjmed.2006.02.014","article-title":"Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia","volume":"119","author":"Frei","year":"2006","journal-title":"Am J Med"},{"key":"2026063005522264800_dlag065-B37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/01.idc.0000155836.70718.30","article-title":"Evaluation of antibiotic usage with a local community-acquired pneumonia guideline","volume":"13","author":"Mazzola","year":"2005","journal-title":"Infect Dis Clin Pract"},{"key":"2026063005522264800_dlag065-B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106189","article-title":"A pharmacist-led prospective antibiotic stewardship intervention improves compliance to community-acquired pneumonia guidelines in 39 public and private hospitals across South Africa","volume":"56","author":"Van Den Bergh","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"2026063005522264800_dlag065-B39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1155\/2002\/697424","article-title":"Characterizing and developing strategies for the treatment of community-acquired pneumonia at a community hospital","volume":"9","author":"Fok","year":"2002","journal-title":"Can Respir J"},{"key":"2026063005522264800_dlag065-B40","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s11096-010-9384-y","article-title":"Implementation of guidelines for sequential therapy with fluoroquinolones in a Belgian hospital","volume":"32","author":"Buyle","year":"2010","journal-title":"Pharm World Sci"},{"key":"2026063005522264800_dlag065-B41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/1062860604273748","article-title":"Getting physicians to make \u201cthe switch\u201d: the role of clinical guidelines in the management of community-acquired pneumonia","volume":"20","author":"Hagaman","year":"2005","journal-title":"Am J Med Qual"},{"key":"2026063005522264800_dlag065-B42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1440-1843.2006.00931.x","article-title":"Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia","volume":"12","author":"Lee","year":"2007","journal-title":"Respirology"},{"key":"2026063005522264800_dlag065-B43","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/jac\/dkq018","article-title":"Reassessment of intravenous antibiotic therapy using a reminder or direct counselling","volume":"65","author":"Lesprit","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"2026063005522264800_dlag065-B44","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4103\/0970-258X.261176","article-title":"Effectiveness of education and antibiotic control programme at All India Institute of Medical Sciences, New Delhi","volume":"31","author":"Wig","year":"2018","journal-title":"Natl Med J India"},{"key":"2026063005522264800_dlag065-B45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1001\/archinte.161.1.61","article-title":"Early discharge of infected patients through appropriate antibiotic use","volume":"161","author":"Eron","year":"2001","journal-title":"Arch Intern Med"},{"key":"2026063005522264800_dlag065-B46","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/S0954-6111(98)90351-1","article-title":"Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis","volume":"92","author":"Omidvari","year":"1998","journal-title":"Respir Med"},{"key":"2026063005522264800_dlag065-B47","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1016\/j.ajic.2015.12.026","article-title":"Evaluating the impact of an antimicrobial stewardship program on the length of stay of immune-competent adult patients admitted to a hospital ward with a diagnosis of community-acquired pneumonia: a quasi-experimental study","volume":"44","author":"Didiodato","year":"2016","journal-title":"Am J Infect Control"},{"key":"2026063005522264800_dlag065-B48","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jsps.2018.04.009","article-title":"Patterns of antibiotic use and administration in hospitalized patients in Jordan","volume":"26","author":"Jarab","year":"2018","journal-title":"Saudi Pharm J"},{"key":"2026063005522264800_dlag065-B49","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1017\/ash.2024.399","article-title":"Acceptance of pharmacist-led stewardship recommendations for patients with community-acquired pneumonia","volume":"4","author":"Walker","year":"2024","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"2026063005522264800_dlag065-B50","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1093\/ajhp\/57.suppl_3.S10","article-title":"Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia","volume":"57","author":"Clark","year":"2000","journal-title":"Am J Med Qual"},{"key":"2026063005522264800_dlag065-B51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/qshc.2005.017327","article-title":"Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study","volume":"16","author":"Schouten","year":"2007","journal-title":"Qual Saf Health Care"},{"key":"2026063005522264800_dlag065-B52","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11096-020-00970-0","article-title":"Physicians\u2019 acceptance of pharmacists\u2019 interventions in daily hospital practice","volume":"42","author":"Zaal","year":"2020","journal-title":"Int J Clin Pharm"},{"key":"2026063005522264800_dlag065-B53","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.20.2449","article-title":"Early switch from intravenous to oral antibiotics and early hospital discharge","volume":"159","author":"Ramirez","year":"1999","journal-title":"Arch Intern Med"},{"key":"2026063005522264800_dlag065-B54","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0002-9343(03)00395-4","article-title":"Implementation of an evidence-based guideline to reduce duration of intravenous antibiotic therapy and length of stay for patients hospitalized with community-acquired pneumonia: a randomized controlled trial","volume":"115","author":"Fine","year":"2003","journal-title":"Am J Med"},{"key":"2026063005522264800_dlag065-B55","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1001\/archinternmed.2012.1690","article-title":"Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia","volume":"172","author":"Carratal\u00e0","year":"2012","journal-title":"Arch Intern Med"},{"key":"2026063005522264800_dlag065-B56","doi-asserted-by":"publisher","first-page":"89S","DOI":"10.1592\/phco.21.10.89s.34535","article-title":"A controlled trial of a critical pathway for treating community-acquired pneumonia: the CAPITAL study. Community-acquired pneumonia intervention trial assessing levofloxacin","volume":"21","author":"Feagan","year":"2001","journal-title":"Pharmacotherapy"},{"key":"2026063005522264800_dlag065-B57","doi-asserted-by":"publisher","first-page":"136","DOI":"10.5414\/CP201579","article-title":"Clinical and economic impact of a pharmacist-managed i.v.-to-p.o. conversion service for levofloxacin in Taiwan","volume":"50","author":"Yen","year":"2012","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2026063005522264800_dlag065-B58","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/jac\/42.1.107","article-title":"The effect of intravenous-to-oral switch guidelines on the use of parenteral antimicrobials in medical wards","volume":"42","author":"Laing","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"2026063005522264800_dlag065-B59","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1017\/ice.2020.347","article-title":"Cluster randomized trial of an antibiotic time-out led by a team-based pharmacist","volume":"41","author":"Van Schooneveld","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026063005522264800_dlag065-B60","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa497","article-title":"A pathway for community-acquired pneumonia with rapid conversion to oral therapy improves health care value","volume":"7","author":"Ciarkowski","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2026063005522264800_dlag065-B61","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/tmi.13911","article-title":"Impact of clinical pharmacist-led interventions on switching from intravenous-to-oral antibiotics in patients with infectious diseases at a Vietnamese hospital","volume":"28","author":"Nguyen","year":"2023","journal-title":"Trop Med Int Health"},{"key":"2026063005522264800_dlag065-B62","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40267-021-00815-4","article-title":"Early conversion of intravenous to oral antibiotic therapy in uncomplicated urinary and respiratory tract infection","volume":"37","author":"Anusha","year":"2021","journal-title":"Drugs Ther Perspect"},{"key":"2026063005522264800_dlag065-B63","doi-asserted-by":"publisher","DOI":"10.18549\/PharmPract.2018.02.855","article-title":"Impact of printed antimicrobial stewardship recommendations on early intravenous to oral antibiotics switch practice in district hospitals","volume":"16","author":"Sze","year":"2018","journal-title":"Pharm Pract"},{"key":"2026063005522264800_dlag065-B64","doi-asserted-by":"publisher","first-page":"FC01","DOI":"10.7860\/JCDR\/2018\/31647.11246","article-title":"Practice of intravenous to oral conversion of antibiotics and its influence on length of stay at a tertiary care hospital: a prospective study","volume":"12","author":"Tejaswini","year":"2018","journal-title":"J Clin Diagn Res"},{"key":"2026063005522264800_dlag065-B65","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s10096-014-2158-z","article-title":"A tailored implementation strategy to reduce the duration of intravenous antibiotic treatment in community-acquired pneumonia: a controlled before-and-after study","volume":"33","author":"Engel","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026063005522264800_dlag065-B66","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1406960","article-title":"The effect of the antibiotic stewardship program (ASP) on community-acquired pneumonia (CAP): a before-after study","volume":"15","author":"F\u00e9s\u00fcs","year":"2024","journal-title":"Front Pharmacol"},{"key":"2026063005522264800_dlag065-B67","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/ajhp\/59.22.2209","article-title":"Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from i.v. to oral","volume":"59","author":"Kuti","year":"2002","journal-title":"Am J Med Qual"},{"key":"2026063005522264800_dlag065-B68","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1001\/archinte.163.21.2585","article-title":"Conversion from intravenous to oral medications\u2014assessment of a computerized intervention for hospitalized patients","volume":"163","author":"Fischer","year":"2003","journal-title":"Arch Intern Med"},{"key":"2026063005522264800_dlag065-B69","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.22037\/ijpr.2019.1100833","article-title":"Antibiotic prescribing trends before and after implementation of an audit and feedback program in internal ward of a tertiary hospital in Tehran","volume":"18","author":"Golali","year":"2019","journal-title":"Iran J Pharm Res"},{"key":"2026063005522264800_dlag065-B70","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1093\/ajhp\/57.suppl_3.S17","article-title":"Approaches to drug therapy, formulary, and pathway management in a large community hospital","volume":"57","author":"Halley","year":"2000","journal-title":"Am J Med Qual"},{"key":"2026063005522264800_dlag065-B71","doi-asserted-by":"publisher","first-page":"S136","DOI":"10.1086\/428054","article-title":"Pharmacoeconomic considerations associated with the use of intravenous-to-oral moxifloxacin for community-acquired pneumonia","volume":"41","author":"Davis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2026063005522264800_dlag065-B72","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10111289","article-title":"Impact of multidisciplinary team escalating approach on antibiotic stewardship in the United Arab Emirates","volume":"10","author":"Sadeq","year":"2021","journal-title":"Antibiotics"},{"key":"2026063005522264800_dlag065-B73","doi-asserted-by":"publisher","author":"Peyrani","DOI":"10.1136\/eb-2012-101000"},{"key":"2026063005522264800_dlag065-B74","first-page":"858","article-title":"Comparison between the efficacy of switch therapy and conventional therapy in pediatric community-acquired pneumonia","volume":"98","author":"In-iw","year":"2015","journal-title":"J Med Assoc Thai"},{"key":"2026063005522264800_dlag065-B75","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/jac\/44.5.709","article-title":"Sequential antimicrobial therapy: treatment of severe lower respiratory tract infections in children","volume":"44","author":"Al-Eidan","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"2026063005522264800_dlag065-B76","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jiac.2017.08.017","article-title":"Effectiveness of an early switch from intravenous to oral antimicrobial therapy for lower respiratory tract infection in patients with severe motor intellectual disabilities","volume":"24","author":"Kawamura","year":"2018","journal-title":"J Infect Chemother"},{"key":"2026063005522264800_dlag065-B77","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.2169\/internalmedicine.47.1343","article-title":"Implication of clinical pathway care for community-acquired pneumonia in a community hospital: early switch from an intravenous.BETA.-lactam plus a macrolide to an oral respiratory fluoroquinolone","volume":"47","author":"Shindo","year":"2008","journal-title":"Intern Med"},{"key":"2026063005522264800_dlag065-B78","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1590\/0037-868217382013","article-title":"Impact of an intervention in the use of sequential antibiotic therapy in a Brazilian university hospital","volume":"46","author":"Melo Rodrigues","year":"2013","journal-title":"Rev Soc Bras Med Trop"},{"key":"2026063005522264800_dlag065-B79","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1136\/ejhpharm-2013-000394","article-title":"An audit of antimicrobial treatment of lower respiratory and urinary tract infections in a hospital setting","volume":"21","author":"Maripuu","year":"2014","journal-title":"Eur J Hosp Pharm"},{"key":"2026063005522264800_dlag065-B80","doi-asserted-by":"publisher","first-page":"710","DOI":"10.4414\/smw.2005.11174","article-title":"Evaluation of prescription practices of antibiotics in a medium-sized Swiss hospital","volume":"135","author":"Di Giammarino","year":"2005","journal-title":"Swiss Med Wkly"},{"key":"2026063005522264800_dlag065-B81","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/jac\/43.4.601","article-title":"Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital","volume":"43","author":"Sevinc","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"2026063005522264800_dlag065-B82","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1183\/09031936.00029412","article-title":"Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP","volume":"41","author":"Engel","year":"2013","journal-title":"Eur Respir J"},{"key":"2026063005522264800_dlag065-B83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003539.pub2","article-title":"Interventions to improve antibiotic prescribing practices in ambulatory care","volume":"2005","author":"Arnold","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"2026063005522264800_dlag065-B84","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1017\/ice.2019.294","article-title":"Antimicrobial stewardship staffing: how much is enough?","volume":"41","author":"Greene","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026063005522264800_dlag065-B85","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40121-015-0080-z","article-title":"Antimicrobial stewardship from policy to practice: experiences from UK antimicrobial pharmacists","volume":"4","author":"Gilchrist","year":"2015","journal-title":"Infect Dis Ther"},{"key":"2026063005522264800_dlag065-B86","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3390\/antibiotics14101039","article-title":"Barriers and enablers to optimal antimicrobial use in respiratory tract infections","volume":"14","author":"Reali","year":"2025","journal-title":"Antibiotics"},{"key":"2026063005522264800_dlag065-B87","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/cid\/cix065","article-title":"Eight habits of highly effective antimicrobial stewardship programs to meet the joint commission standards for hospitals","volume":"64","author":"Goff","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2026063005522264800_dlag065-B88","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1186\/s12879-017-2673-5","article-title":"Monitoring, documenting and reporting the quality of antibiotic use in The Netherlands: a pilot study to establish a national antimicrobial stewardship registry","volume":"17","author":"Berrevoets","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2026063005522264800_dlag065-B89","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1017\/ice.2020.383","article-title":"Inpatient fluoroquinolone use in veterans\u2019 affairs hospitals is a predictor of Clostridioides difficile infection due to fluoroquinolone-resistant ribotype 027 strains","volume":"42","author":"Silva","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026063005522264800_dlag065-B90","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1017\/ice.2016.328","article-title":"A report of the efforts of the veterans health administration national antimicrobial stewardship initiative","volume":"38","author":"Kelly","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026063005522264800_dlag065-B91","doi-asserted-by":"publisher","author":"Wang","DOI":"10.1016\/j.ijmedinf.2022.104778"},{"key":"2026063005522264800_dlag065-B92","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1186\/s12879-025-11027-w","article-title":"Incidence and risk factor of sepsis in patients with severe community-acquired pneumonia: a Chinese, single-center, retrospective study","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Infect Dis"},{"key":"2026063005522264800_dlag065-B93","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3390\/antibiotics13060546","article-title":"Accordance of registered drug packages with guideline-recommended treatment durations for community-acquired pneumonia\u2014a new antibiotic stewardship target?","volume":"13","author":"Prusac","year":"2024","journal-title":"Antibiotics"},{"key":"2026063005522264800_dlag065-B94","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/IPC.0b013e318068b1c0","article-title":"Summary of the Infectious Diseases Society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"15","author":"Dellit","year":"2007","journal-title":"Infect Dis Clin Pract"},{"key":"2026063005522264800_dlag065-B95","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the society for healthcare epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026063005522264800_dlag065-B96","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026063005522264800_dlag065-B97","author":"Hanson"},{"key":"2026063005522264800_dlag065-B98","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1177\/0009922819852985","article-title":"Scope of antibiotic stewardship programs in pediatrics","volume":"58","author":"Grammatico-Guillon","year":"2019","journal-title":"Clin Pediatr"},{"key":"2026063005522264800_dlag065-B99","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/jac\/dkae440","article-title":"Trends in fluoroquinolone prescribing in UK primary and secondary care between 2019 and 2023","volume":"80","author":"Hamilton","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"2026063005522264800_dlag065-B100","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11101312","article-title":"Effect of reduced fluoroquinolone use on cephalosporin use, susceptibilities and Clostridioides difficile infections","volume":"11","author":"Wren","year":"2022","journal-title":"Antibiotics"},{"key":"2026063005522264800_dlag065-B101","doi-asserted-by":"publisher","first-page":"251","DOI":"10.20411\/pai.v4i2.327","article-title":"Impact of reduced fluoroquinolone use on clostridioides difficile infections resulting from the fluoroquinolone-resistant ribotype 027 strain in a veterans affairs medical center","volume":"4","author":"Redmond","year":"2019","journal-title":"Pathog Immun"},{"key":"2026063005522264800_dlag065-B102","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.54565","article-title":"Fluoroquinolones: neurological complications and side effects in clinical practice","volume":"16","author":"Anwar","year":"2024","journal-title":"Cureus"},{"key":"2026063005522264800_dlag065-B103","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030804","article-title":"Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile?","volume":"15","author":"Rusu","year":"2023","journal-title":"Pharmaceutics"},{"key":"2026063005522264800_dlag065-B104","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/01.JAA.0000873776.37967.9b","article-title":"A preventable, life-altering case of fluoroquinolone-associated tendonitis","volume":"35","author":"Wildermuth","year":"2022","journal-title":"Jaapa"},{"key":"2026063005522264800_dlag065-B105","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1177\/10600280211031390","article-title":"Antibiotic approvals in the last decade: are we keeping up with resistance?","volume":"56","author":"Chahine","year":"2022","journal-title":"Ann Pharmacother"},{"key":"2026063005522264800_dlag065-B106","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/dtb.2023.000069","article-title":"MHRA issues two updates on fluoroquinolone safety","volume":"62","author":"Anonymous","year":"2024","journal-title":"Drug Ther Bull"},{"key":"2026063005522264800_dlag065-B107","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/dtb.2024.000021","article-title":"MHRA issues further update on fluoroquinolone safety","volume":"62","author":"Anonymous","year":"2024","journal-title":"Drug Ther Bull"},{"key":"2026063005522264800_dlag065-B108","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2019-000714","article-title":"Development and application of \u2018systems thinking\u2019 principles for quality improvement","volume":"9","author":"McNab","year":"2020","journal-title":"BMJ Open Qual"},{"key":"2026063005522264800_dlag065-B109","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1001\/jama.2012.7551","article-title":"Understanding health care as a complex system","volume":"308","author":"Lipsitz","year":"2012","journal-title":"JAMA"},{"key":"2026063005522264800_dlag065-B110","doi-asserted-by":"publisher","first-page":"i37","DOI":"10.1093\/ijpp\/riad021.044","article-title":"499 exploring intern doctors\u2019 views and experiences of prescribing at hospital discharge: a qualitative interview study","volume":"31","author":"Nicolaou-Ghekas","year":"2023","journal-title":"Int J Pharm Pract"},{"key":"2026063005522264800_dlag065-B111","author":"England"},{"key":"2026063005522264800_dlag065-B112","doi-asserted-by":"publisher","DOI":"10.1093\/jamiaopen\/ooae109","article-title":"Advancing patient-centered clinical decision support in today\u2019s health care ecosystem: key themes from the clinical decision support innovation collaborative\u2019s 2023 annual meeting","volume":"7","author":"Dullabh","year":"2024","journal-title":"JAMIA Open"},{"key":"2026063005522264800_dlag065-B113","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1197\/jamia.M1809","article-title":"Overriding of drug safety alerts in computerized physician order entry","volume":"13","author":"Van Der Sijs","year":"2006","journal-title":"J Am Med Inform Assoc"},{"key":"2026063005522264800_dlag065-B114","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy11040119","article-title":"Pharmacists\u2019 perceptions on safety alerts of the drug utilization review (DUR) in electronic health records in a tertiary healthcare hospital","volume":"11","author":"Alshehri","year":"2023","journal-title":"Pharmacy"},{"key":"2026063005522264800_dlag065-B115","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12911-021-01710-8","article-title":"Safer prescription of drugs: impact of the PREFASEG system to aid clinical decision-making in primary care in Catalonia","volume":"21","author":"Pons-Mesquida","year":"2021","journal-title":"BMC Med Inform Decis Mak"},{"key":"2026063005522264800_dlag065-B116","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1093\/jamia\/ocaa154","article-title":"A machine learning\u2013based clinical decision support system to identify prescriptions with a high risk of medication error","volume":"27","author":"Corny","year":"2020","journal-title":"J Am Med Inform Assoc"},{"key":"2026063005522264800_dlag065-B117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0039-3402715","article-title":"Reducing alert burden in electronic health records: state of the art recommendations from four health systems","volume":"11","author":"McGreevey","year":"2020","journal-title":"Appl Clin Inform"},{"key":"2026063005522264800_dlag065-B118","doi-asserted-by":"publisher","DOI":"10.3390\/life13020376","article-title":"Pleural space infections","volume":"13","author":"Foley","year":"2023","journal-title":"Life"},{"key":"2026063005522264800_dlag065-B119","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.2147\/IJGM.S292705","article-title":"Recent insights into the management of pleural infection","volume":"14","author":"Hassan","year":"2021","journal-title":"Int J Gen Med"},{"key":"2026063005522264800_dlag065-B120","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1080\/17476348.2022.2147508","article-title":"Pharmacokinetics of antibiotics for pleural infection","volume":"16","author":"Lau","year":"2022","journal-title":"Expert Rev Respir Med"},{"key":"2026063005522264800_dlag065-B121","doi-asserted-by":"publisher","DOI":"10.1177\/20499361211073248","article-title":"Evaluation of step-down oral antibiotic therapy for uncomplicated streptococcal bloodstream infections on clinical outcomes","volume":"9","author":"Kang","year":"2022","journal-title":"Ther Adv Infect Dis"},{"key":"2026063005522264800_dlag065-B122","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12879-021-05919-w","article-title":"Systematic review: the bioavailability of orally administered antibiotics during the initial phase of a systemic infection in non-icu patients","volume":"21","author":"van den Broek","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2026063005522264800_dlag065-B123","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/jac\/dkp131","article-title":"Outcomes of early switching from intravenous to oral antibiotics on medical wards","volume":"64","author":"Mertz","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"2026063005522264800_dlag065-B124","author":"GOV.UK"},{"key":"2026063005522264800_dlag065-B125","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1002\/ehf2.15373","article-title":"Intense optimization of oral therapy rapidly restores respiratory function in worsening heart failure patients","volume":"12","author":"Yaakoubi","year":"2025","journal-title":"ESC Heart Fail"},{"key":"2026063005522264800_dlag065-B126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153721","article-title":"The role of hospital inpatients in supporting medication safety: a qualitative study","volume":"11","author":"Garfield","year":"2016","journal-title":"PLoS One"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/8\/3\/dlag065\/68269390\/dlag065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/8\/3\/dlag065\/68269390\/dlag065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:58:57Z","timestamp":1782817137000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlag065\/8676065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":126,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlag065","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,4,30]]},"article-number":"dlag065"}}